Delivery Order SPE2DB20D3101-SPE2DB25FRUV9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 11, 2025, with a ceiling value of $3,388.86. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency (DLA) awarded a $1,479.55 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 29, 2025. This firm fixed-price contract, awarded on August 28, 2025, represents a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.66 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of July 22, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $2,551.20 and ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,166.08. This firm fixed price delivery order represents a non-competitive set-aside award and is scheduled for completion by July 31, 2025. The award was performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,838.68 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price contract, which has no set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,618.27 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price, non-set-aside contract was delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order represents a standard pharmaceutical procurement mechanism under the federal medical supply chain. This award is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,300.40 on August 14, 2025, for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $4,938.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania, supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $5,028.35. This competitively awarded, firm fixed-price delivery order is set to conclude by September 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUV9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on September 9, 2025, with a contract ceiling value of $2,257.08. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. This comprehensive pharmaceutical support vehicle enables the contractor to supply a wide range of medications, medical supplies, and healthcare commodities to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen's contract portfolio demonstrates consistent capability to meet DLA requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/9/25 |